Arcutis Biotherapeutics

1 Follower

About

Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing best-in-class products.

Frank Watanabe
President and CEO
Frank Watanabe
Collapse
David Osborne
Chief Technical Officer
Kenneth Lock
Chief Commercial Officer
Patrick Burnett
Chief Medical Officer
Matthew Moore
Chief Business Officer
Raj Madan
Chief Digital & Information Officer
Keith Klein
General Counsel
Patricia Turney
Senior Vice President, Operations
Courtney Barton
Vice President, Chief Compliance Officer & Chief of Staff
David Berk
Vice President, Clinical Development
Scott Burrows
Vice President, Finance
Bethany Dudek
Vice President, Quality
Meg Elias
Vice President, Clinical Operations
Ayisha Jeter
Vice President, Market Access
Kimberly Lathroum
Vice President, Marketing
Charlotte Merritt
Vice President, Regulatory Affairs
Frank Pompilio
Vice President, Medical Affairs
Jay Ramsinghani
Vice President, Commercial Strategy and Operations
Gregory Sukay
Vice President, Manufacturing & Process Technologies
Corey Padovano
Vice President, Sales

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.